Buchbesprechungen

The Science of Nature -     

Studies on the use of power ultrasound in solid–liquid myrobalan extraction process

Focus on eco-friendly processing techniques makes vegetable tanning a viable option in leather processing and establishes the subsequent need for the more efficient methods of extraction in tannin manufacture. Application of ultrasound has been tried in the extraction of tannins from myrobalan nuts in order to improve the extraction efficiency, to perform the extraction under milder process conditions and to reduce the process time. The influence of process parameters such as ultrasonic output power, time and temperature has been studied. Scale-up trials and the use of ultrasound in pulse mode have also been attempted. The results show that a three- to fivefold improvement is possible with ultrasonic output from 20 to 100 W. Extraction efficiency has been calculated from the maximum extractable materials from myrobalan nuts. Extraction efficiency is found to be 90% for ultrasound, 100 W without external heating as compared to 77% for control process at 70 °C for 4 h. Therefore, ultrasound could be employed even dispensing with provision for temperature controls. The use of ultrasound in pulse mode offered 70% extraction efficiency of continuous mode. Scale-up trials indicate that there exists an optimum ultrasonic output power depending on the amount of nuts used, to achieve better extraction efficiency. The effectiveness of ultrasonically extracted tannin solution has also been tested in the tanning process for its applicability. The degree of tanning efficacy has been assessed by shrinkage temperature measurement. The results indicate that ultrasonically extracted tannin solution is suitable for tanning process. Therefore, application of ultrasound in tannin extract manufacture is a viable option with added advantages.     

The in utero diagnosis and management of alloimmune thrombocytopenia

A case is presented in which percutaneous umbilical sampling (PUBS) was utilized in the second and third trimesters for the diagnosis and management of a pregnancy at risk for neonatal alloimmune thrombocytopenia (NAIT).